Search Results 581-590 of 17018 for pharmacogenetics
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...
About this study. The purpose of this study is to gain stepwise understanding of the fundamental biology governing human antitumor immunity, by systematic ...
Access to care. Analysis of secondary data. Artificial intelligence. Biostatistics. Economic and health technology evaluations. Evaluation of clinical practice ...
About this study. The short-term goal of this study is to inform the process and mechanisms to enrich URM patient accrual to interventional cancer treatment ...
Genetic Variations May Help Identify Best Candidates for Preventive Breast Cancer Drugs. ROCHESTER, Minn. — Newly discovered genetic variations may help ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
About this study. This protocol is being conducted to determine the mechanisms responsible for insulin resistance, obesity and type 2 diabetes.
Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary objective of the study is to compare sacituzumab tirumotecan combined with ...
Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...
About this study. The purpose of this study is to evaluate the dose, safety, immunogenicity and early clinical activity of GRT-C903 and GRT-R904, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.